Journey Strategic Wealth’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.72M Hold
12,829
0.17% 41
2025
Q4
$7.47M Buy
12,829
+1
+0% +$511 0.2% 38
2025
Q3
$5.88M Sell
12,828
-250
-2% -$93.3K 0.17% 44
2025
Q2
$3.96M Hold
13,078
0.13% 59
2025
Q1
$4.33M Hold
13,078
0.15% 48
2024
Q4
$4.04M Sell
13,078
-250
-2% -$70.3K 0.15% 43
2024
Q3
$2.83M Buy
13,328
+3
+0% +$767 0.1% 51
2024
Q2
$3.73M Buy
13,325
+5
+0% +$1.19K 0.16% 32
2024
Q1
$3.56M Hold
13,320
0.16% 31
2023
Q4
$3.08M Hold
13,320
0.15% 29
2023
Q3
$1.95M Sell
13,320
-31
-0.2% -$5.83K 0.09% 35
2023
Q2
$3.08M Sell
13,351
-503
-4% -$136K 0.14% 29
2023
Q1
$3.36M Sell
13,854
-7
-0.1% -$1.91K 0.35% 23
2022
Q4
$4.02M Buy
13,861
+36
+0.3% +$3.52K 0.47% 20
2022
Q3
$898K Buy
13,825
+5
+0% +$347 0.12% 46
2022
Q2
$989K Hold
13,820
0.13% 41
2022
Q1
$1.36M Hold
13,820
0.15% 20
2021
Q4
$1.17M Buy
+13,820
New +$1.14M 0.12% 38

Other funds holding MDGL